What we found on the web about Rapamycin
Sirolimus - Wikipedia, the free encyclopedia
Sirolimus (INN / USAN), also known as rapamycin, is an immunosuppressant drug used to prevent rejection in organ transplantation; it is especially useful in kidney transplants.
Mammalian target of rapamycin - Wikipedia, the free encyclopedia
The mammalian target of rapamycin (mTOR) also known as FK506 binding protein 12-rapamycin associated protein 1 (FRAP1) is a protein which in humans is encoded by the FRAP1 gene.
rapamycin - Hutchinson encyclopedia article about rapamycin
Antibiotic and immunosuppressive drug produced by the micro-organism Streptomyces hygroscopius. It is used to prevent bacterial infections and for use as an immunosuppressive in ...
San Francisco Sentinel » Blog Archives » EASTER ISLAND COMPOUND ...
If rapamycin, or drugs like rapamycin, works as envisioned, the potential reduction in overall health cost for the U.S. and the world will be enormous.”
US 5616588 - Rapamycin formulation for IV injection
Disclosed herein is an aqueous, injectable rapamycin solution comprising 40 to 75 volume percent of a concentrate solution of rapamycin in propylene glycol, at
mTOR, Rapamycin, and Lifespan: A Startling Study. In the Pipeline:
About this Author Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt ...
Register for FREE
Please register to gain free access to WSJ tools. An account already exists for the email address entered. There’s a bit off buzz around a drug called rapamycin this morning: A ...
US 7160867 - Rapamycin carbohydrate derivatives
This invention provides modified rapamycins that have specific monosaccharide(s), oligosaccharide(s), pseudosugar(s) or derivatives thereof attached through a
Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated ...
The mammalian target of rapamycin (mTOR) has emerged as an important cancer therapeutic target. Rapamycin and its derivatives that specifically inhibit mTOR are now being actively ...
Rapamycin extends life in mice, raising hopes of life-prolonging drug ...
A drug used by transplant patients can extend the lives of mice by about a third, according to research that raises the prospect of a life-prolonging pill for people. Male mice ...
Wyeth.com | Rapamune® (sirolimus)
Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal and ...
Huntington's Disease Information - HOPES - Rapamycin, H5
Drug summary: Rapamycin, also known as sirolimus, is an FDA-approved antibiotic and immunosuppressant. It is already being used in organ transplant patients and is currently being ...
rapamycin - definition of rapamycin in the Medical dictionary - by the ...
rapamycin. a macrolide compound obtained from Streptomyces hygroscopicus used as an immunosuppressant in tissue transplantation. rapamycin. Sirolimus, see there
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Rapamycin

Sirolimus (INN/USAN), also known as rapamycin, is an immunosuppressant drug used to prevent rejection in organ transplantation; it is especially useful in kidney transplants. A macrolide, sirolimus was first discovered as a product of the bacterium Streptomyces hygroscopicus in a soil sample from Easter Island — an island also known as "Rapa Nui", hence the name. It is marketed under the trade name Rapamune by Wyeth.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Rapamycin
Scientists find path to fountain of youth
Yahoo News
As rapamycin is already used in humans as an immunosuppresant -- to prevent a patient from rejecting an organ after transplant -- it could not be administered as an anti-ageing drug in its current form. But rapamycin blocks S6K1 activity an...
Anti-aging without a pill
Sheknows.com
For example, the latest drug claiming to extend life expectancy is Rapamycin, derived from the soil found in Easter Island. The July 2009 issue of the journal Nature reports that this miracle pill was able to reduce mid-life mortality risk ...
Gene Switch Adds ‘Life’ to Years, Years to Life in Mouse Study
Bloomberg
The organ transplant drug rapamycin, sold by Wyeth, interrupts the activity of S6K1. “We are suddenly much closer to treatments for aging than we thought,” David Gems, one of the study’s authors, said in the statement. “We have moved from ....
Marshall Edwards, Inc.'s NV-128, a Novel mTOR Inhibitor, Demonstrates ...
Market Wire
Rapamycin and its analogs are regarded as the archetypal inhibitors of mammalian target of rapamycin or mTOR. In addition to their reported toxicities, rapalogs have been shown to contribute to the development of drug resistant tumors and u...
Easter Island compound extends lifespan of old mice
Science Centric
Rapamycin appears to partially shut down the same molecular pathway as restricting food intake or reducing growth factors. It does so through a cellular protein called mTOR (mammalian target of rapamycin), which controls many processes in c...
Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
TMCnet
(continued) 187 table 89 structure-function approach for rapamycin 188 table 90 biotica projects pipeline 189 blue heron biotechnologies 190 bristol-myers squibb 190 bristol-myers squibb (continued) 191 british petroleum 192 cellicon ...
UT Health Science Center ranks fourth in Texas in stimulus grants
San Antonio Business Journal
This money will allow the university’s Barshop Institute for Longevity and Aging Studies to study whether the drug compound rapamycin can deter age-related diseases and improve quality of life. The lead investigator is Arlan G. Richardson, ...